關鍵數據
5.100今開
5.250最高
1.01M成交量
虧損本益比TTM
虧損本益比動
--股利TTM
1.01%換手率
5.070昨收
4.860最低
3.63M成交額
虧損本益比靜
-29.84市淨率
0.00%股息率 TTM
-26.19%ROA
4.88052週最高
0.71量比
-53.01M淨利潤
99.97M總股本
-0.3566每股盈餘TTM
0.39Beta
-3410.47%ROE
2.01552週最低
7.69%振幅
14.72%毛利率
485.87M總市值
-1.44回報/風險
4.71%風險率
操作建議
Oncology Institute Inc當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在醫療服務供應商行業排名42/75位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為8.40。中期看,股價處於上升通道。近一個月,市場表現較差,但基本面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。
Oncology Institute Inc評分
壓力支撐

由於公司未披露,未能獲取相關數據
Oncology Institute Inc亮點
亮點風險
Oncology Institute Inc新聞
即將為您帶來更多新聞,敬請期待。 。 。
收益預測
Oncology Institute Inc
TOI
5
技術指標
財務指標
每股收益

由於公司未披露,未能獲取相關數據
營業總收入

由於公司未披露,未能獲取相關數據
Oncology Institute Inc簡介
The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
公司代碼TOI
公司Oncology Institute Inc
CEOVirnich (Daniel)
網址https://theoncologyinstitute.com/
公司股東
常見問題
Oncology Institute Inc(TOI)的當前股價是多少?
Oncology Institute Inc(TOI)的當前股價是 4.86。
Oncology Institute Inc 的股票代碼是什麼?
Oncology Institute Inc的股票代碼是TOI。
Oncology Institute Inc股票的52週最高點是多少?
Oncology Institute Inc股票的52週最高點是4.88。
Oncology Institute Inc股票的52週最低點是多少?
Oncology Institute Inc股票的52週最低點是2.02。
Oncology Institute Inc的市值是多少?
Oncology Institute Inc的市值是485.87M。
現在Oncology Institute Inc(TOI)的股票是買入、持有還是賣出?
根據分析師評級,Oncology Institute Inc(TOI)的總體評級為買入,目標價格為8.40。
Oncology Institute Inc(TOI)股票的每股收益(EPS TTM)是多少
Oncology Institute Inc(TOI)股票的每股收益(EPS TTM)是-0.54。